Pathology and Diagnostics News

Filtered by July 2020 Remove date search

  • National Pathology and Diagnostics July 2020 Newsletter

    UTL v0.5.0 Released

    Dear All,

    As Pathology stakeholders we recently notified you of the publication of the Unified Test List (UTL) V0.5.0. in human readable form on our Pathology and Diagnostics collaborative workspace.

    This release includes:

    • A sample of microorganism nucleic acid SNOMED CT reporting concepts by presence of RNA/DNA. These are specimen and technology/method neutral codes adhering to a proposed design decision to capture the postcoordinated and associated specimen and technology/method SNOMED CT concepts within the message specification. However, whether or not to add precoordinated specimens to microorganism nucleic acid SNOMED CT content in future UTL releases is still under consideration.
    • A sample of microorganism susceptibility to antimicrobial SNOMED CT reporting concepts. These are organism neutral codes adhering to a proposed design decision to capture the postcoordinated and associated microorganism SNOMED CT concept within the message specification.

    The columns for the attributes including substance, property and specimen are included purely for information. They are in development.  No use of these columns is planned at this stage.  They will ultimately be used to formally classify the SNOMED content using the observable entity concept model, where the attributes and corresponding values will be used to create the SNOMED CT machine readable description logic definitions.

    Please use the links below to access the updated UTL v0.5.0 documentation on our site:

    To provide feedback on the release as a whole, please contact us via our team mailbox: pathologyanddiagnostics@nhs.net  or alternatively contact us to request membership to our collaboration site in order to contribute to our UTL discussion forum 

    We offer a mechanism to allow users to easily send feedback or questions to us on a specific UTL concept, via a link on each item in the downloadable HTML-format review copy of the UTL. Please download the UTL v0.5.0 release and use the “feedback link” displayed against each line item in the HTML documents within the review package zip file.

    As a Pathology and Diagnostics stakeholder, you will have recently received an email with MS Teams meeting details for a UTL workshop scheduled to take place on the 15th July. The workshop will provide an opportunity for us to provide an overview of the v0.5.0 release and address any feedback received so far.

    Guidance for naming, coding and processing SARS-COV-2 Pathology Tests

    The Pathology Business Product team have been involved in reviewing and updating the guidance for the national naming, coding and processing of SARS-COV-2 Pathology tests which now contains additional information for Labs and LIMS on naming requestable and reportable items related  to SARS-COV-2 Testing. Working with the RCPath and the Pathology Standards Governance board (PSGB), a detailed set of requestable and reportable items has been created to help laboratories and LIMS suppliers define COVID19 related data items.

    Requesting and Test Sets (Panels)

    The team have been performing analysis on LIMS data extracts provided by Harrogate and Poole trusts and have also been analysing requesting data provided by a software supplier in the UK. These organisations have agreed to make the data available to the project, and to the wider stakeholder group, in support of the overall aims of the project.

    Based on the data provided so far, the team have developed a Requesting and Panels design options and decisions document and are beginning to engage with other labs in order to form a broader picture of requesting codes and practice across the country.

    Pathology Informatics National User Group (PINUG)

    The Pathology Informatics National User Group (PINUG) aims to encourage a two-way dialogue between NHS Digital and other interested parties, allowing us to successfully align with all stakeholder group requirements.   

    The group meets every two months via MS Teams and consists of clinicians, diagnostic professionals and system suppliers.  The meetings are chaired by our lead clinician, who is a member of the Royal College of Pathologists (RCPath).

    The forum allows us to provide parties with key updates and encourages stakeholders to share relevant news and information with us.

    We have recently scheduled a new series of bi-monthly PINUG meetings up until March 2021

    If you would like to be part of the PINUG please email us at Pathologyanddiagnostics@nhs.net for regular meeting invites and updates.

    Pathology Standards Governance board (PSGB)

    The Pathology Standards Governance Board (PSGB) is a cross-organisational expert group which provides oversight of the development, maintenance and release of the UTL with SNOMED CT concepts, including the Units of Measure

    (UoM) and pathology standard-related elements which are agreed by the board.

    The Governance Board comprises core members who oversee the development and maintenance of the UTL and extended members, who provide advice, support and feedback whilst keeping their organisations informed and facilitating

    endorsement where relevant.

    Throughout April and May the PSGB were instrumental in helping NHS Digital develop the guidance for the national naming, coding and processing of SARS-COV-2 Pathology tests.

    The next bi-monthly PSGB meeting is due to take place on 22nd July and will resume focus on the development of the UTL and associated Pathology information standards.

    By Chris Hood 2 years ago

    Read this article

  • UTL v0.5.0 Release

    Dear All,

    We are pleased to announce the release of the UTL V0.5.0.

    This release includes:

    1) A sample of microorganism nucleic acid SNOMED CT reporting concepts by presence of RNA/DNA. These are specimen and technology/method neutral codes adhering to a proposed design decision to capture the postcoordinated and associated specimen and technology/method SNOMED CT concepts within the message specification. However, whether or not to add precoordinated specimens to microorganism nucleic acid SNOMED CT content in future UTL releases is still under consideration.

    2) A sample of microorganism susceptibility to antimicrobial SNOMED CT reporting concepts. These are organism neutral codes adhering to a proposed design decision to capture the postcoordinated and associated microorganism SNOMED CT concept within the message specification.

    The columns for the attributes including substance, property and specimen are included purely for information. They are in development.  No use of these columns is planned at this stage.  They will ultimately be used to formally classify the SNOMED content using the observable entity concept model, where the attributes and corresponding values will be used to create the SNOMED CT machine readable description logic definitions.

    Please use the links below to access the updated UTL v0.5.0 documentation:

     To provide feedback on the release as a whole, please use the UTL discussion forum or email pathologyanddiagnostics@nhs.net 

     We are also trialling a mechanism to allow users to easily send feedback or questions to us on a specific UTL concept, via a link on each item in the downloadable HTML-format review copy of the UTL. Please download the UTL v0.5.0 release and use the “feedback link” displayed against each line item in the HTML documents within the review package zip file.

     As a Pathology and Diagnostics stakeholder you will shortly receive an invitation for a workshop on the 15th July where the team will provide an overview of the release and address any feedback received.

    By Harriet Inglis 2 years ago

    Read this article